VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Tuesday, December 30, 2025

Stock Comparison

Bio-Rad Laboratories, Inc. vs The Clorox Company

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Bio-Rad Laboratories, Inc.

BIO · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-30
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.

View BIO analysis

The Clorox Company

CLX · New York Stock Exchange

Market cap (USD)
SectorConsumer
CountryUS
Data as of2025-12-25
Moat score
57/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into The Clorox Company's moat claims, evidence, and risks.

View CLX analysis

Comparison highlights

  • Moat score gap: Bio-Rad Laboratories, Inc. leads (61 / 100 vs 57 / 100 for The Clorox Company).
  • Segment focus: Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics); The Clorox Company has 9 segments (33% in Cleaning (U.S.)).
  • Moat breadth: Bio-Rad Laboratories, Inc. has 6 moat types across 3 domains; The Clorox Company has 4 across 3.

Primary market context

Bio-Rad Laboratories, Inc.

Clinical Diagnostics

Market

In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls

Geography

Global

Customer

Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories

Role

IVD OEM / installed-base consumables supplier (systems + kits + controls)

Revenue share

59.9%

The Clorox Company

Cleaning (U.S.)

Market

U.S. household cleaning & disinfecting products

Geography

United States

Customer

Consumers

Role

Brand owner / manufacturer

Revenue share

33%

Side-by-side metrics

Bio-Rad Laboratories, Inc.
The Clorox Company
Ticker / Exchange
BIO - New York Stock Exchange
CLX - New York Stock Exchange
Market cap (USD)
n/a
n/a
Sector
Healthcare
Consumer
HQ country
US
US
Primary segment
Clinical Diagnostics
Cleaning (U.S.)
Market structure
Oligopoly
Oligopoly
Market share
9%-11% (implied)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
61 / 100
57 / 100
Moat domains
Supply, Demand, Legal
Demand, Supply, Legal
Last update
2025-12-30
2025-12-25

Moat coverage

Shared moat types

Distribution ControlInstalled Base ConsumablesCompliance Advantage

Bio-Rad Laboratories, Inc. strengths

Scope EconomiesCapex Knowhow ScaleSwitching Costs General

The Clorox Company strengths

Brand Trust

Segment mix

Bio-Rad Laboratories, Inc. segments

Full profile >

Life Science

Competitive

40.1%

Clinical Diagnostics

Oligopoly

59.9%

The Clorox Company segments

Full profile >

Cleaning (U.S.)

Oligopoly

33%

Professional Products (U.S.)

Oligopoly

5%

Bags and Wraps (U.S.)

Duopoly

11%

Cat Litter (U.S.)

Oligopoly

9%

Grilling (U.S.)

Oligopoly

8%

Food (U.S.)

Competitive

11%

Water Filtration (U.S.)

Oligopoly

4%

Natural Personal Care (U.S.)

Competitive

3%

International (Ex-U.S.)

Competitive

15%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.